NATIONAL NEUROSCIENCE INSTITUTE
πΈπ¬Singapore
- Country
- πΈπ¬Singapore
- Ownership
- -
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.nni.com.sg/
Clinical Trials
10
Active:1
Completed:2
Trial Phases
3 Phases
Phase 2:4
Phase 4:1
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
5 (50.0%)Phase 2
4 (40.0%)Phase 4
1 (10.0%)Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- National Neuroscience Institute
- Target Recruit Count
- 12
- Registration Number
- NCT06894225
- Locations
- πΈπ¬
National Neuroscience Institute, Singapore, Singapore
uSINE-PAMS Artificial Intelligence Driven, Ultrasound-Guided Lumbar Puncture to Improve Procedural Accuracy
Not Applicable
Recruiting
- Conditions
- Ultrasound TherapyLumbar Puncture
- First Posted Date
- 2023-04-21
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- National Neuroscience Institute
- Target Recruit Count
- 50
- Registration Number
- NCT05824546
- Locations
- πΈπ¬
National Neuroscience Institute (NNI), Singapore, Singapore
Genotype Guided Antiplatelet Therapy in Ischemic Stroke
Not Applicable
Recruiting
- Conditions
- Ischemic StrokeTransient Ischemic Attack
- First Posted Date
- 2023-03-10
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- National Neuroscience Institute
- Target Recruit Count
- 350
- Registration Number
- NCT05763862
- Locations
- πΈπ¬
Singapore General Hospital, Singapore, Singapore
RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation
Not Applicable
Recruiting
- Conditions
- Chronic Spinal Cord Injury
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2023-03-14
- Lead Sponsor
- National Neuroscience Institute
- Target Recruit Count
- 3
- Registration Number
- NCT05644171
- Locations
- πΈπ¬
National Neuroscience Institute, Singapore, Singapore
EGb 761 in the Syndrome of MCI With Concomitant CVD
Phase 2
Recruiting
- Conditions
- Mild Cognitive ImpairmentCerebrovascular Disease
- Interventions
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- National Neuroscience Institute
- Target Recruit Count
- 134
- Registration Number
- NCT04525144
- Locations
- πΈπ¬
National Neuroscience Institute, Singapore, Singapore
- Prev
- 1
- 2
- Next
News
Singapore MOH Investigates Ethical Lapses in Neuroscience Research Study
A Ministry of Health (MOH) committee investigated ethical concerns in a National Neuroscience Institute (NNI) study involving Parkinson's Disease, epilepsy, stroke and tardive dyskinesia patients.